Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ROL | Help please... claiming shareholder funds | 06:11 | 1 | 2.5K | |||
|
|||||||
ROL | Hugh Thomas - The real reason for the destruction of Robust | 11/08/15 | 25 | 19K | |||
|
|||||||
ROL | Ann: Removal from Official List | 17/11/14 | 0 | 1.4K | |||
|
|||||||
ROL | Ann: Appendix 3X | 05/11/14 | 0 | 1.2K | |||
|
|||||||
ROL | Ann: Change of registered office | 03/11/14 | 0 | 1.2K | |||
|
|||||||
ROL | Ann: Appendix 3X | 03/11/14 | 0 | 1.2K | |||
|
|||||||
ROL | Ann: Suspension from Official Quotation - close of trade 3/11/14 | 03/11/14 | 0 | 1.2K | |||
|
|||||||
ROL | Ann: Appendix 5B - 30 Sep 2014 | 31/10/14 | 0 | 918 | |||
|
See All Discussions